CAS: 1034616-18-6
NMS-P937 (NMS1286937)
CAS:1034616-18-6
Formula:
C24H27F3N8O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
532.5182
Ref: AN-AG008TIK
5mg | 183.00 € | |
25mg | 325.00 € | |
100mg | To inquire |
Estimated delivery in United States, on Thursday 16 May 2024
Onvansertib
CAS:1034616-18-6
Onvansertib (NMS-1286937), an oral, specific Polo-like Kinase 1 (PLK1) inhibitor, is with IC50 of 2 …
Formula:
C24H27F3N8O3
Purity:
99.88%
Color and Shape:
Solid
Molecular weight:
532.52
Ref: TM-T6247
2mg | 46.00 € | |
5mg | 69.00 € | |
10mg | 96.00 € | |
25mg | 147.00 € | |
50mg | 222.00 € | |
100mg | 370.00 € | |
200mg | 475.00 € | |
500mg | 775.00 € | |
1ml*10 (DMSO) | 81.00 € |
Estimated delivery in United States, on Thursday 23 May 2024
Ref: TR-N631750
250mg | 20,168.00 € |
Estimated delivery in United States, on Wednesday 26 Jun 2024
4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carb oxamide
CAS:1034616-18-6
4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carb oxamide is a drug for the treatment of pediatric cancer. This compound is a …
Formula:
C24H27F3N8O3
Purity:
Min. 95%
Molecular weight:
532.52 g/mol
Ref: 3D-FD103869
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire |
Estimated delivery in United States, on Thursday 27 Jun 2024